Artificial intelligence expands diagnostic horizons in coronary angiography

FHS
May 3, 2024
11:46 am

New insights from the AI-ENCODE study showed artificial intelligence (AI) successfully allowed the automated extraction of key functional and physiological data from routine angiograms.

Meta Title: Seres Therapeutics Inc Files Patent for Dysbiosis Treatment Capsule Formula

Share this article According to GlobalData’s company profile on Seres Therapeutics, Microbiota restoration therapy was a key innovation area identified from patents. Seres Therapeutics‘s grant

April 24, 2024

Accelerated approval brings Pfizer’s BRAF inhibitor to first-line patients

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

December 21, 2024

BIO-Europe 2023: Small oncology biotechs require creative financing approaches – Pharmaceutical Technology

The panel discussion featuring (L-R) Lucie Ellis-Taitt, executive director In Vivo Citeline, Jean-Paul Kress, CEO, Morphosys and Susanne Schaffert, board director, Novo Holding, Incyte, Galapagos,

November 7, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.